To overcome this, in a separate analysis, we pooled the sepsis and COVID-19 groups and found significantly higher tubulointerstitial properdin deposition in thrombi-positive biopsies (2.41 [1.39–3.60] vs. 0.87 [0.27–1.36], P = 0.003). The gene discussed is CFP; the disease is COVID-19.